Search Results - "Tyrcha, Urszula"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    IGF2 Peptide-Based LYTACs for Targeted Degradation of Extracellular and Transmembrane Proteins by Mikitiuk, Michał, Barczyński, Jan, Bielski, Przemysław, Arciniega, Marcelino, Tyrcha, Urszula, Hec, Aleksandra, Lipińska, Andrea D, Rychłowski, Michał, Holak, Tad A, Sitar, Tomasz

    Published in Molecules (Basel, Switzerland) (01-11-2023)
    “…Lysosome-targeting chimeras (LYTACs) have recently been developed to facilitate the lysosomal degradation of specific extracellular and transmembrane molecular…”
    Get full text
    Journal Article
  2. 2

    N-methylmorpholine incorporation into the structure of biphenyl leads to the bioactive inhibitor of PD-1/PD-L1 interaction by Zaber, Julia, Skalniak, Lukasz, Gudz, Ganna P., Hec-Gałązka, Aleksandra, Zarnik, Magdalena, Tyrcha, Urszula, Stec, Malgorzata, Siedlar, Maciej, Holak, Tad A., Sitar, Tomasz, Muszak, Damian

    Published in Bioorganic & medicinal chemistry letters (15-09-2024)
    “…[Display omitted] •Utility of N-methylmorpholine derivatives as inhibitors of PD-L1 protein.•Optimal elongation path determination of N-methylmorpholine in the…”
    Get full text
    Journal Article
  3. 3

    Nonsymmetrically Substituted 1,1′-Biphenyl-Based Small Molecule Inhibitors of the PD-1/PD-L1 Interaction by Hec-Gałązka, Aleksandra, Tyrcha, Urszula, Barczyński, Jan, Bielski, Przemyslaw, Mikitiuk, Michał, Gudz, Ganna P., Kitel, Radosław, Musielak, Bogdan, Plewka, Jacek, Sitar, Tomasz, Holak, Tad A.

    Published in ACS medicinal chemistry letters (13-06-2024)
    “…Therapeutic antibodies directed against either programmed cell death-1 protein (PD-1) or its ligand PD-L1 have demonstrated efficacy in the treatment of…”
    Get full text
    Journal Article